Fang Ting, Wang Cheng-Long, Zhang Yan, Zhu Rui, Lin Yue, Dai Qin-Xi, Cai Shu, Chen Lai-Wei, Wen Xiao-Ling
Department of Radiology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Quant Imaging Med Surg. 2025 Mar 3;15(3):2258-2269. doi: 10.21037/qims-24-1748. Epub 2025 Feb 26.
Type 2 diabetes mellitus (T2DM) and silicosis both have significant impacts on cardiopulmonary health. However, there is a lack of research investigating whether the presence of T2DM causes additional damage to the heart and lungs of patients with silicosis. This study aims to assess the alterations in pulmonary and cardiac structures, as well as lung function, in patients with silicosis who also have T2DM, and to explore the factors influencing lung function.
We included 30 silicosis patients with T2DM and 30 silicosis patients without diabetes. The two groups were matched by age, silicosis stage, smoking history, and dust exposure duration. Demographic details, occupational history, hematological results, computed tomography (CT)-measured cardiac and lung parameters, and pulmonary function test (PFT) results were collected. We compared these parameters between the two groups, evaluated the correlation between lung function and CT parameters in the diabetic group, and analyzed factors affecting lung function in this group.
The silicosis combined with T2DM group showed significantly higher values for body mass index (BMI), the longest diameters from left to right of the left ventricle (LVLR), blood glucose, and triglycerides compared to the silicosis but without T2DM group (all P<0.05). The silicosis combined with T2DM group showed significantly lower total lung mass, and the ratio of forced expiratory volume in one second to forced vital capacity (FEV1/FVC) compared to the silicosis but without T2DM group (all P<0.05). In the silicosis with T2DM group, FEV1/FVC ratio showed significant correlations with total lung mass, the longest diameters from left to right of the left atrium, LVLR, and the longest diameters from left to right of the right atrium (r values were 0.51, 0.47, 0.40, and 0.44, respectively; all P<0.05). Multivariate analysis revealed that BMI and the LVLR were independent determinants of FEV1/FVC ratio in the silicosis with T2DM group (t values were -3.367 and 2.471, respectively; all P<0.05).
Diabetes mellitus induces structural changes in the lungs and heart of patients with silicosis and exacerbates the impairment of lung function. BMI and LVLR are key determinants of the FEV1/FVC ratio highlighting the need for enhanced comprehensive management strategies.
2型糖尿病(T2DM)和矽肺均对心肺健康有重大影响。然而,缺乏关于T2DM的存在是否会对矽肺患者的心脏和肺部造成额外损害的研究。本研究旨在评估合并T2DM的矽肺患者的肺和心脏结构改变以及肺功能,并探讨影响肺功能的因素。
我们纳入了30例合并T2DM的矽肺患者和30例无糖尿病的矽肺患者。两组在年龄、矽肺分期、吸烟史和粉尘接触时间方面进行匹配。收集人口统计学细节、职业史、血液学结果、计算机断层扫描(CT)测量的心脏和肺部参数以及肺功能测试(PFT)结果。我们比较了两组之间的这些参数,评估了糖尿病组肺功能与CT参数之间的相关性,并分析了该组中影响肺功能的因素。
与无T2DM的矽肺组相比,合并T2DM的矽肺组的体重指数(BMI)、左心室左右最长径(LVLR)、血糖和甘油三酯值显著更高(均P<0.05)。与无T2DM的矽肺组相比,合并T2DM的矽肺组的肺总质量和一秒用力呼气量与用力肺活量之比(FEV1/FVC)显著更低(均P<0.05)。在合并T2DM的矽肺组中,FEV1/FVC比值与肺总质量、左心房左右最长径、LVLR和右心房左右最长径显著相关(r值分别为0.51、0.47、0.40和0.44;均P<0.05)。多因素分析显示,BMI和LVLR是合并T2DM的矽肺组中FEV1/FVC比值的独立决定因素(t值分别为-3.367和2.471;均P<0.05)。
糖尿病会导致矽肺患者的肺部和心脏结构改变,并加剧肺功能损害。BMI和LVLR是FEV1/FVC比值的关键决定因素,这突出了加强综合管理策略的必要性。